DailyUpdates by e-mail - the publication tracker for the drug discovery community
Psychiatric, Addictive & Sleep Disorders channel
|If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, , links through to full analyses relating to pharmaceutical/market developments relating to this work||
Do you need further information on any of the agents being evaluated in the trial(s) below? Let us know...
New Clinical Trials
Previous Journal Entries
FRAS1-related extracellular matrix 3 (FREM3) single-nucleotide polymorphism effects on gene expression, amygdala reactivity and perceptual processing speed: An accelerated aging pathway of depression risk.
Rational Design, Pharmacomodulation, Synthesis of Dual 5 - Hydroxytryptamine 7 (5 - HT7) / 5 - Hydroxytryptamine 2A (5 - HT2A) Receptors Antagonists and Evaluation by [(18)F] - PET Imaging in a Primate Brain.
Disruption of glucocorticoid receptors in the noradrenergic system leads to BDNF up - regulation and altered serotonergic transmission associated with a depressive - like phenotype in female GR(DBHCre) mice.
Ethylenedioxy homologs of N - methyl - (3,4 - methylenedioxyphenyl) - 2 - aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
Psychometric properties of the incontinence utility index among patients with idiopathic overactive bladder: data from two multicenter, double-blind, randomized, Phase 3, placebo-controlled clinical trials.
Training Courses & Meetings
No events listed
Previous News Items